Core Insights - Tandem Diabetes Care, Inc. has launched the t:slim X2 insulin pump integrated with Abbott's FreeStyle Libre 3 Plus CGM sensor in the U.S. This marks the beginning of a global commercial rollout aimed at enhancing choice and personalization for diabetes patients [1] Company Overview - Tandem Diabetes Care, Inc. is a global player in insulin delivery and diabetes technology, focusing on innovative solutions for diabetes management [1] Product Launch - The t:slim X2 insulin pump features Control-IQ+ automated insulin delivery technology, which is now available with the integration of Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring sensor [1] Market Impact - The integration of these technologies is expected to provide expanded options for individuals living with diabetes, enhancing their management capabilities [1]
t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States